Skip to main content

Table 1 Clinical characteristic of the hepatocellular carcinoma patients

From: Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma

Patient ID Age Sex Pathological type Size of tumor BCLC stage HBsAg (IU/mL) HBV-DNA (IU/mL) AFP (ng/mL) ALT(U/L) AST(U/L)
1 58 M Moderately differentiated 32 × 22 mm A > 180 8.69E+3 1073 40.7 33.3
2 47 M Poorly differentiated 28 × 25 mm A 29.86 1.06E+2 1.43 248.2 183.2
3 64 M Moderately differentiated 77 × 71 mm B > 180 1.08E+5 110 25.8 55.1
4 60 M Moderately to poorly differentiated 106 × 73 mm C 159.58 3.24E+2 16.09 33.6 46
5 61 M Moderately differentiated 16 × 17 mm O > 250 5.89E+2 766.5 16 12.9
6 46 M Moderately to poorly differentiated 27 × 28 mm A > 180 2.60E+5 4371 37.2 25.7
7 38 M Moderately differentiated 25 × 24 mm A 251.9 < 100 0.746 35 43
8 76 M S8:Well-differentiated
S7:Moderately to poorly differentiated
15 × 13 mm O 1.17 < 100 unknown 28 28
9 57 M Moderately differentiated 27 × 19 mm A > 250 5.05E+03 3.129 20 16
10 64 M Well-differentiated 24 × 20 mm A 2165 < 100 5.06 24 22
11 53 M Moderately differentiated 62 × 63 mm B 1070 4.21E+05 3.516 32 53
12 45 M Moderately differentiated 81 × 51 mm B > 180 1.21E+2 855.5 23.5 19.2